1 FEV1 change from baseline |
5 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
1.1 BUD |
2 |
84 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.37 [‐0.06, 0.81] |
1.2 FP |
2 |
215 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.07 [‐0.20, 0.34] |
1.3 BDP |
1 |
237 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.07 [‐0.19, 0.32] |
2 Morning PEF (L/min) change baseline |
5 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
2.1 BUD |
3 |
196 |
Mean Difference (IV, Fixed, 95% CI) |
10.69 [‐2.78, 24.16] |
2.2 FP |
2 |
215 |
Mean Difference (IV, Fixed, 95% CI) |
11.63 [‐2.64, 25.91] |
3 Evening PEF (L/min) change from baseline |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
3.1 BUD |
2 |
181 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.52 [‐13.55, 12.51] |
3.2 FP |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
13.00 [‐4.52, 30.52] |
4 PEF Diurnal Variation change from baseline |
2 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
4.1 BUD |
2 |
126 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.28 [‐0.63, 0.07] |
5 Symptom Score change baseline |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
5.1 BUD |
1 |
15 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.70 [‐1.26, ‐0.14] |
5.2 FP |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
0.03 [‐0.15, 0.21] |
6 Symptoms (night waking) change from baseline |
3 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
6.1 BUD |
1 |
70 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.0 [‐0.47, 0.47] |
6.2 FP |
2 |
215 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.39 [‐0.66, ‐0.12] |
7 Rescue Medications (no. of puffs) change baseline |
4 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
7.1 BUD |
1 |
15 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.4 [‐1.23, 0.43] |
7.2 FP |
2 |
215 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.28 [‐1.29, 0.73] |
7.3 BDP |
1 |
237 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.32 [‐3.29, 2.65] |
8 Withdrawal due to Adverse Event |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
8.1 BUD |
1 |
130 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.71 [0.16, 3.03] |
8.2 FP |
1 |
156 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.32 [0.37, 4.72] |
8.3 BDP |
1 |
237 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.03 [0.06, 16.21] |
9 Adverse Events |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
9.1 BUD |
1 |
70 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
9.2 FP |
2 |
216 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.08 [0.93, 1.27] |
9.3 BDP |
1 |
237 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.01 [0.86, 1.20] |
10 Oral Candidiasis |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
10.1 BUD |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
10.2 FP |
2 |
311 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.34, 2.39] |
11 Exacerbations |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11.1 BUD |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
11.2 FP |
1 |
156 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.42, 1.35] |
11.3 BDP |
1 |
237 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.54 [0.26, 9.04] |
12 Plasma Cortisol below reference range |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12.1 BUD |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
12.2 FP |
1 |
162 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.49 [0.13, 1.88] |
12.3 BDP |
1 |
237 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.68 [0.29, 1.61] |